Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Nov;18(6):1324-1333.
doi: 10.1177/19322968241248404. Epub 2024 May 24.

Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review

Peter Adolfsson  1   2 , Ragnar Hanas  1   3 , Dessi P Zaharieva  4 , Klemen Dovc  5   6 , Johan Jendle  7   8
Affiliations
Review

Automated Insulin Delivery Systems in Pediatric Type 1 Diabetes: A Narrative Review

Peter Adolfsson et al. J Diabetes Sci Technol. 2024 Nov.

Abstract

This narrative review assesses the use of automated insulin delivery (AID) systems in managing persons with type 1 diabetes (PWD) in the pediatric population. It outlines current research, the differences between various AID systems currently on the market and the challenges faced, and discusses potential opportunities for further advancements within this field. Furthermore, the narrative review includes various expert opinions on how different AID systems can be used in the event of challenges with rapidly changing insulin requirements. These include examples, such as during illness with increased or decreased insulin requirements and during physical activity of different intensities or durations. Case descriptions give examples of scenarios with added user-initiated actions depending on the type of AID system used. The authors also discuss how another AID system could have been used in these situations.

Keywords: automated insulin delivery; exercise; hybrid closed loop; illness; pediatric; type 1 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: PA has received honoraria for speaking engagements from Eli Lilly, Novo Nordisk, Sanofi, Dexcom, Insulet, Medtronic, Nordic InfuCare, Rubin Medical and Tandem, and is on an advisory board for Eli Lilly, Novo Nordisk, Sanofi, Insulet, Medtronic, and Roche. RH has received honoraria for work on an advisory board for Abbot. DPZ has received honoraria for speaking engagements from Ascensia Diabetes, Insulet Canada, and Medtronic, and is on an advisory board for Dexcom; and has received an ISPAD_JDRF Research Fellowship and research support from Insulet and the Leona M, and Harry B. Helmsley Charitable Trust. KD received honoraria for participation in the speaker’s bureau of Abbott, Eli Lilly, Medtronic, NovoNordisk A/S, and Pfizer; and has received an ISPAD-JDRF Research Fellowship. JJ has received honoraria for speaking engagements from Eli Lilly, Boehringer Ingelheim, Nordic InfuCare, Novo Nordisk, Sanofi, and is on an advisory board for Abbott, Eli Lilly, and Medtronic.

Figures

Figure 1.
Figure 1.
Summarized overview of current recommendations related to planned exercise.
See this image and copyright information in PMC

References

    1. Battelino T, Danne T, Bergenstal RM, et al.. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42(8):1593-1603. - PMC - PubMed
    1. Pintus D, Ng SM. Freestyle libre flash glucose monitoring improves patient quality of life measures in children with type 1 diabetes mellitus (T1DM) with appropriate provision of education and support by healthcare professionals. Diabetes Metab Syndr. 2019;13(5):2923-2926. - PubMed
    1. Šoupal J, Petruželková L, Grunberger G, et al.. Glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study. Diabetes Care. 2020;43(1):37-43. - PubMed
    1. Cengiz E, Danne T, Ahmad T, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: insulin treatment in children and adolescents with diabetes. Pediatr Diabetes. 2022;23(8):1277-1296. - PubMed
    1. de Bock M, Codner E, Craig ME, et al.. ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes. 2022;23(8):1270-1276. - PMC - PubMed